Thursday, April 19, 2018 12:01:14 PM
You are correct, I was underwhelmed too. I can see seeking private placement when canopy doesn't have the funds, another thing that is questionable to me is the medical arm. I am still in because even with the big money taking the prime stake I feel there is enough for all of us. The instant they "separate" into different companies or start showing tweed as unprofitable when the other two are going gang busters I will reconsider. So far in my opinion Canopy has been the least self serving compared to some other options in this space
Recent WEED News
- Canopy Growth Launches Deep Space Infused Pre-Rolls • Business Wire • 07/10/2025 11:30:00 AM
- Canopy Growth Appoints Tom Stewart as Interim Chief Financial Officer • Business Wire • 07/09/2025 12:55:00 PM
- Storz & Bickel Named “Equipment Provider of the Year” at Business of Cannabis Awards 2025 • Business Wire • 07/08/2025 11:30:00 AM
- Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results • Business Wire • 05/30/2025 11:00:00 AM
- Canopy Growth to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 30, 2025 • Business Wire • 05/16/2025 11:30:00 AM
- Canopy Growth Drives Innovation in High-Demand Segments With Latest Product Launches • Business Wire • 05/06/2025 11:30:00 AM
